About Klinikum Innenstadt
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
2
Biogen
1
Ipsen
1
Taiho Oncology, Inc.
1
Clinical Trials at Klinikum Innenstadt
During the past decade, Klinikum Innenstadt conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
2005-01-01
2008-01-01
Completed
38
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
2013-07-01
2014-06-01
Terminated
18
A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).
2015-08-19
2018-09-24
Terminated
21
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Innenstadt"
#1 collaborator was "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinikum Innenstadt
According to Clinical.Site data, the most researched conditions in "Klinikum Innenstadt" are
"Chronic Lymphocytic Leukemia" (2 trials), "Acromegaly" (1 trials), "Small Cell Lung Cancer (SCLC)" (1 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "Klinikum Innenstadt" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Innenstadt
Most popular intervention types in "Klinikum Innenstadt" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (2 trials), "Amrubicin (Japan)" (1 trials), "Chlorambucil" (1 trials), "Nusinersen" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Innenstadt
The vast majority of trials in "Klinikum Innenstadt" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum Innenstadt
Currently, there are NaN active trials in "Klinikum Innenstadt".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum Innenstadt,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Innenstadt, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".